首页> 外文期刊>Nutrition >Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-A meta-analysis
【24h】

Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-A meta-analysis

机译:补充大豆异黄酮可减轻非亚裔绝经后妇女的体重并改善其葡萄糖代谢-荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The objective of this study was to conduct a systematic review and a meta-analysis to confirm the effects of soy isoflavone supplementation on body weight, fasting glucose, and insulin level in non-Asian postmenopausal women. Methods: We searched the PubMed, EMBASE, and Cochrane databases up to October 2010 for randomized controlled trials regarding the effects of isoflavone supplementation on body weight, fasting glucose, and insulin level. Pooled estimates and 95% confidence intervals (CIs) were calculated by the fixed-and-random-effects model. Results: Nine studies with 528 participants for body weight, 11 studies with 1182 participants for fasting glucose, and 11 studies with 1142 participants for fasting insulin were included, respectively. Significant reductions were found in body weight [weighted mean difference (WMD), -0.515; 95%CI: -0.895 to -0.134; P = 0.008), glucose level (WMD, -0.189; 95%CI: -0.344 to -0.033), and fasting insulin level (WMD, -0.940; 95%CI: -1.721 to -0.159) with soy isoflavone supplementation compared with placebo control group in non-Asian postmenopausal women after adjusted by unpublished studies. Furthermore, isoflavone supplementation in shorter duration (<6 mo) could significantly reduce body weight (WMD, -0.506; 95%CI: -0.888 to -0.124; P = 0.009) and longer duration (≥6 mo) could significantly reduce blood glucose in postmenopausal women (WMD, -0.270; 95%CI: -0.430 to -0.110; P = 0.001). Meanwhile, more reduction in body weight was observed in the lower dose subgroup (dose < 100 mg). Moreover, it is more effective to reduce body weight and fasting insulin level with soy isoflavone supplementation in normal weight (body mass index < 30) than obese (body mass index ≥ 30) women. Conclusions: This meta-analysis showed soy isoflavone supplementation could be beneficial for body weight reduction, glucose, and insulin control in plasma. Large and well-designed studies are recommended to confirm this conclusion.
机译:目的:本研究的目的是进行系统的回顾和荟萃分析,以确认补充大豆异黄酮对非亚裔绝经后妇女的体重,空腹血糖和胰岛素水平的影响。方法:我们搜索了截至2010年10月的PubMed,EMBASE和Cochrane数据库,以了解补充异黄酮对体重,空腹血糖和胰岛素水平的影响的随机对照试验。通过固定和随机效应模型计算汇总估计值和95%置信区间(CI)。结果:分别包括9项研究,其中528名参与者参加了体重研究,11项研究中的1182名参与者参加了空腹血糖研究,以及11项研究中的1142参与者参加了空腹胰岛素研究。体重显着降低[加权平均差异(WMD),-0.515; 95%CI:-0.895至-0.134; P = 0.008),补充大豆异黄酮的葡萄糖水平(WMD,-0.189; 95%CI:-0.344至-0.033)和空腹胰岛素水平(WMD,-0.940; 95%CI:-1.721至-0.159)与经未发表的研究调整后,非亚洲绝经后妇女的安慰剂对照组。此外,持续时间较短(<6个月)的异黄酮补充剂可显着降低体重(WMD,-0.506; 95%CI:-0.888至-0.124; P = 0.009),持续时间较长(≥6个月)可显着降低血糖在绝经后妇女中(WMD,-0.270; 95%CI:-0.430至-0.110; P = 0.001)。同时,在较低剂量的亚组(剂量<100 mg)中观察到体重进一步减轻。此外,在正常体重(体重指数<30)的情况下,补充大豆异黄酮比肥胖(体重指数≥30)的妇女更有效地减轻体重和空腹胰岛素水平。结论:这项荟萃分析显示,补充大豆异黄酮可能有助于降低体重,降低血糖和控制血浆中的胰岛素。建议进行大型且设计合理的研究以证实这一结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号